Recruiting
Phase 3

Tenofovir to Prevent HBV Reactivation

Sponsor:

University Health Network, Toronto

Code:

NCT02186574

Conditions

Hepatitis B

Lymphoma

Non-Hodgkin

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tenofovir disoproxil

Placebo Oral Tablet

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information